NASDAQ:BCAX | Profit Breakdown | Bicara Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$59.95M-$55.38M-$55.44M
2026-03-31-$60.24M-$56.16M-$56.21M
2025-12-31-$41.12M-$37.33M-$37.39M
2025-09-30-$40.68M-$36.29M-$36.33M
2025-06-30-$32.02M-$27.34M-$27.39M
2025-03-31-$41.79M-$36.77M-$36.85M
2024-12-31-$26.64M-$20.77M-$20.96M
2024-09-30-$20.63M-$17.48M-$17.48M
2024-06-30-$19.75M-$17.05M-$17.05M
2024-03-31-$15.37M-$12.51M-$12.51M
2023-12-31-$13.69M-$12.44M-$12.44M
2023-09-30-$9.53M-$22.85M-$22.85M
2023-06-30-$9.29M
2023-03-31-$7.41M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$155.6M-$137.73M-$137.95M
2024-12-31-$82.39M-$67.81M-$68M
2023-12-31-$39.89M-$51.98M-$51.99M